LSC - 2022 - Identification of a host antiviral and anti-inflammatory metabolite that protects against influenza virus-driven morbidity and mortality
A. Cezard (Tours, France), D. Brea-Diakite (Tours, France), V. Vasseur (Tours, France), L. Gonzales (Tours, France), R. Le Goffic (Jouy-en-Josas, France), B. Da Costa (Jouy-en-Josas, France), D. Fouquenet (Tours, France), T. Baranek (Tours, France), C. Paget (Tours, France), A. Guillon (Tours, France), M. Si-Tahar (Tours, France)
Source: International Congress 2022 – Basic science of respiratory infection
Session: Basic science of respiratory infection
Session type: Thematic Poster
Number: 1829
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Cezard (Tours, France), D. Brea-Diakite (Tours, France), V. Vasseur (Tours, France), L. Gonzales (Tours, France), R. Le Goffic (Jouy-en-Josas, France), B. Da Costa (Jouy-en-Josas, France), D. Fouquenet (Tours, France), T. Baranek (Tours, France), C. Paget (Tours, France), A. Guillon (Tours, France), M. Si-Tahar (Tours, France). LSC - 2022 - Identification of a host antiviral and anti-inflammatory metabolite that protects against influenza virus-driven morbidity and mortality. 1829
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|